אולטיים סיקרטס - הידרייטינג ג'ל מאסק
אלידה ישראל בעמ - לחות ורעננות לעור
אקספולייטינג קלינסינג פאודר + פי סי אם קומפלקס
אלידה ישראל בעמ - שיפור מראה העור
פיטוגן מסיכת פיל אוף - אנטיאוקסידנט
אלידה ישראל בעמ - הזנת עור הפנים
רמיקד
j-c health care ltd - infliximab 100 mg/vial - powder for concentrate for infusion - infliximab - - adult :crohn's disease: treatment of severe active crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. treatment of fistulising crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. -paediatric crohn's disease: remicade is indicated for: treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. remicade has been studied only in combination with conventional immunosuppressive therapy -ankylosing spondylitis: remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional ther